Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

被引：0
|
作者：
Adeniyi Olagunju
Adeola Fowotade
Ajibola Olagunoye
Temitope Olumuyiwa Ojo
Bolanle Olufunlola Adefuye
Adeniyi Francis Fagbamigbe
Akindele Olupelumi Adebiyi
Omobolanle Ibitayo Olagunju
Olabode Taiwo Ladipo
Abdulafeez Akinloye
Babatunde Ayodeji Adeagbo
Adedeji Onayade
Oluseye Oladotun Bolaji
Christian Happi
Steve Rannard
Andrew Owen
机构：
[1] Obafemi Awolowo University,Department of Pharmaceutical Chemistry, Faculty of Pharmacy
[2] University of Liverpool,Department of Molecular and Clinical Pharmacology
[3] University of Ibadan,Department of Medical Microbiology and Parasitology, College of Medicine
[4] State Specialist Hospital,Department of Community Health, Faculty of Clinical Sciences
[5] Obafemi Awolowo University Teaching Hospital,Department of Epidemiology and Medical Statistics, Faculty of Public Health
[6] Olabisi Onabanjo University Teaching Hospital,Department of Community Medicine
[7] University of Ibadan,Department of Surveillance and Epidemiology
[8] University of Ibadan,African Centre of Excellence for Genomics of Infectious Diseases
[9] Nigeria Centre for Disease Control,Department of Chemistry, School of Physical Sciences
[10] Oyo State Ministry of Health,undefined
[11] Redeemer’s University,undefined
[12] University of Liverpool,undefined
来源：
Trials | / 22卷
关键词：
COVID-19; SARS-CoV-2; nitazoxanide; atazanavir/ritonavir; randomised controlled trial; protocol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Rilinger, Jonathan
    Kern, Winfried V.
    Duerschmied, Daniel
    Supady, Alexander
    Bode, Christoph
    Staudacher, Dawid L.
    Wengenmayer, Tobias
    TRIALS, 2020, 21 (01)
  • [22] The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Haddad, Maryam
    Arabi, Mohsen
    Hooshyar, Dariush
    KazemiJahromi, Mitra
    TRIALS, 2020, 21 (01)
  • [23] The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Maryam Haddad
    Mohsen Arabi
    Dariush Hooshyar
    Mitra KazemiJahromi
    Trials, 21
  • [24] Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
    Constantinos Pantos
    Georgia Kostopanagiotou
    Apostolos Armaganidis
    Athanasios Trikas
    Ioulia Tseti
    Iordanis Mourouzis
    Trials, 21
  • [25] Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
    Pantos, Constantinos
    Kostopanagiotou, Georgia
    Armaganidis, Apostolos
    Trikas, Athanasios
    Tseti, Ioulia
    Mourouzis, Iordanis
    TRIALS, 2020, 21 (01)
  • [26] Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
    Prasan Kumar Panda
    Arkapal Bandyopadhyay
    Budha Charan Singh
    Bikram Moirangthem
    Gaurav Chikara
    Sarama Saha
    Yogesh Arvind Bahurupi
    Trials, 21
  • [27] Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial
    Panpan Liu
    Zhijun Huang
    Mingzhu Yin
    Chun Liu
    Xiang Chen
    Pinhua Pan
    Yehong Kuang
    Trials, 21
  • [28] Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial
    Liu, Panpan
    Huang, Zhijun
    Yin, Mingzhu
    Liu, Chun
    Chen, Xiang
    Pan, Pinhua
    Kuang, Yehong
    TRIALS, 2020, 21 (01)
  • [29] A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
    Fowotade, Adeola
    Bamidele, Folasade
    Egbetola, Boluwatife
    Fagbamigbe, Adeniyi F.
    Adeagbo, Babatunde A.
    Adefuye, Bolanle O.
    Olagunoye, Ajibola
    Ojo, Temitope O.
    Adebiyi, Akindele O.
    Olagunju, Omobolanle I.
    Ladipo, Olabode T.
    Akinloye, Abdulafeez
    Onayade, Adedeji
    Bolaji, Oluseye O.
    Rannard, Steve
    Happi, Christian
    Owen, Andrew
    Olagunju, Adeniyi
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection-a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
    Panda, Prasan Kumar
    Bandyopadhyay, Arkapal
    Singh, Budha Charan
    Moirangthem, Bikram
    Chikara, Gaurav
    Saha, Sarama
    Bahurupi, Yogesh Arvind
    TRIALS, 2020, 21 (01)
12345